Association between Plasma P‐tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease
Annals of Neurology · 2026-06 · 99 (6) · 1428-1437
DOI: 10.1002/ana.78201 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Annals of Neurology, online erschienen am 18.03.2026. Verfasst von Thomas F Tropea und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Pennsylvania, Philadelphia, PA. Hauptthemen laut MEDLINE: tau Proteins, Parkinson Disease, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIA NIH HHS, NINDS NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Objective
Clinically relevant Alzheimer's disease co‐pathology is common in Lewy body disorders. Plasma P‐tau217 is a sensitive biomarker for amyloid and tau pathology in Alzheimer's disease. The objective was to determine if plasma P‐tau217 associates with Alzheimer's disease co‐pathology and cognition in Lewy body disorders.
Methods
Participants had (1) a clinicopathological diagnosis of Parkinson's disease or dementia with Lewy bodies in the pathology series, or (2) a clinical diagnosis of Parkinson's disease in the clinical series and were followed as part of the longitudinal, observational cohort study at the University of Pennsylvania between 2007 and 2024. Plasma concentration of P‐tau217 was measured in previously collected samples.
Results
Neuropathology cases included 46 Parkinson's disease and 10 dementia with Lewy bodies, and clinical cases included 173 Parkinson's disease, and 64 controls. P‐tau217 was greater in cases with (median, 0.3 [interquartile range (IQR), 0.2–0.4]) versus without (median, 0.1 [IQR, 0.1–0.2]) Alzheimer's disease co‐pathology ( p < 0.01) and discriminates Lewy body disorders participants with Alzheimer's disease co‐pathology (area under curve, 0.84). Parkinson's disease participants with incident cognitive impairment had greater increases in serial P‐tau217 than those who remained cognitively stable (group × time interaction β = −0.010, p = 0.0027). Higher baseline P‐tau217 concentrations associated with longitudinal change in dementia rating scale (group × time interaction β = −4.947, p = 0.0166) and higher risk for cognitive progression (hazard ratio = 1.597, p = 0.003).
Interpretation
Plasma P‐tau217 detects Alzheimer's disease co‐pathology in Lewy body disorders and predicts cognitive decline. Future studies will evaluate associations between plasma P‐tau217 and imaging and clinical outcomes, in consideration for use of amyloid‐targeting therapies in Lewy body disorders. ANN NEUROL 2026;99:1428–1437
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Pennsylvania, Philadelphia, PA.
- Eli Lilly and Company.
- Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA.
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA.
ORCID-Profile: Emily C Collins, David Irwin, Katheryn A Q Cousins, Leslie Shaw
Förderung
- NIH HHS
- NIA NIH HHS
- NINDS NIH HHS
- National Institutes of Health
Zitieren
APA
Tropea, T. F., Stevenson, P. A., Flitter, M., Meehan, D., Morris, A., Lu, M., Iaccarino, L., Collins, E. C., Hodsdon, M. E., Irwin, D., Spindler, M., Deik, A., Dahodwala, N., Cousins, K. A. Q., Wolk, D. A., Shaw, L., Weintraub, D., Lee, E. B., Chen-Plotkin, A., …, & Siderowf, A. (2026). Association between Plasma P‐tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease. Annals of Neurology, 99(6), 1428-1437. https://doi.org/10.1002/ana.78201
Vancouver
Tropea TF, Stevenson PA, Flitter M, Meehan D, Morris A, Lu M, et al. Association between Plasma P‐tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease. Annals of Neurology. 2026;99(6):1428-1437. doi:10.1002/ana.78201
BibTeX
@article{Tropea2026,
author = {Tropea, Thomas F and Stevenson, Patricia Aldea and Flitter, Matthew and Meehan, David and Morris, Amanda and Lu, Ming and Iaccarino, Leonardo and Collins, Emily C and Hodsdon, Michael E and Irwin, David and Spindler, Meredith and Deik, Andres and Dahodwala, Nabila and Cousins, Katheryn A Q and Wolk, David A and Shaw, Leslie and Weintraub, Daniel and Lee, Edward B and Chen-Plotkin, Alice and Mintun, Mark and Siderowf, Andrew},
title = {Association between Plasma P‐tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease},
journal = {Annals of Neurology},
year = {2026},
volume = {99},
number = {6},
pages = {1428--1437},
doi = {10.1002/ana.78201}
}
EUVIMED